Hemophilia Inhibitor Previously Untreated Patient Study
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Hemophilia A
Related studies linked through entity extraction aliases.
Personalized Prediction of Tolerance and Immunogenicity in Hemophilia
- Status
- UNKNOWN
- Phase
- N/A
Safety, Efficacy and Pharmacokinetics of GreenGene™ F to Previously Treated Patients With Severe Hemophilia A
- Status
- UNKNOWN
- Phase
- PHASE3
BAX 855 Dose-Escalation Safety Study
- Status
- COMPLETED
- Phase
- PHASE1
Study on Von Willebrand Disease and Hemophilia in Cuenca, Ecuador
- Status
- COMPLETED
- Phase
- N/A
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Relative Bioavailability Of Two Formulations Of Moroctocog Alfa (AF-CC)
- Status
- COMPLETED
- Phase
- PHASE1
Inhibitor Development in Patients With Hemophilia A Undergoing Surgery
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of Recombinant Factor VIII (GreenGene) in Patients With Hemophilia A
- Status
- COMPLETED
- Phase
- PHASE3
Non Neutralizing Antibodies: Prevalence and Characterization
- Status
- WITHDRAWN
- Phase
- N/A
Socialization of Adult Men With Congenital Hemophilia A or B
- Status
- COMPLETED
- Phase
- N/A
An Open-label Safety, Efficacy and Pharmacokinetic Study of a Recombinant FVIII Compared to Recombinant Human Antihemophilic FVIII in Patients With Severe Hemophilia A
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Internet-based Educational Program to Promote Self-Management for Teens With Hemophilia
- Status
- COMPLETED
- Phase
- NA
Osteoporosis and MRI Study in Hemophilia
- Status
- TERMINATED
- Phase
- NA
Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Recombinant Coagulation Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Pediatric Subjects With Hemophilia A
- Status
- COMPLETED
- Phase
- PHASE3
Long-Term Safety and Efficacy of rFVIIIFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia A
- Status
- COMPLETED
- Phase
- PHASE3
Study of Biostate for Treatment of Children With Hemophilia A Complicated by Antibody Development
- Status
- TERMINATED
- Phase
- PHASE3
Phase 1 Safety, Pharmacokinetics And Pharmacodynamics Study Of Recombinant Factor VIIa Variant (813d) In Adult Subjects With Hemophilia
- Status
- COMPLETED
- Phase
- PHASE1
Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Congenital Hemophilia A
- Status
- TERMINATED
- Phase
- PHASE3
Kogenate FS Regulatory Post-Marketing Surveillance
- Status
- COMPLETED
- Phase
- N/A